Arsani William - 30 Mar 2021 Form 4/A - Amendment Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
30 Mar 2021
Transactions value $
$14,000,000
Form type
4/A - Amendment
Filing time
06 Sep 2023, 18:13:04 UTC
Date Of Original Report
01 Apr 2021
Next filing
02 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DSGN Common Stock Conversion of derivative security +1.22M 1.22M 30 Mar 2021 By Logos Opportunities Fund II, L.P. F1, F2, F3
transaction DSGN Common Stock Conversion of derivative security +815K 815K 30 Mar 2021 By Logos SPV 1 LP F1, F2, F3
transaction DSGN Common Stock Purchase $14M +700K $20.00 700K 30 Mar 2021 By Logos Global Master Fund LP F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
F2 This Form 4 is being amended to correct the amount of securities beneficially owned by the Reporting Person. This error resulted in the misreporting of the amount of securities beneficially owned by the Reporting Person on subsequent reports.
F3 Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II") and Logos SPV 1 LP ("SPV 1"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. Logos Opportunities II GP LLC ("GP II") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.